The NTAGI has now not but urged any exchange within the agenda of Bharat Biotech's Covaxin, whose 2nd dose is run 28 days after the primary dose.
The NTAGI has now not but urged any exchange within the agenda of Bharat Biotech's Covaxin, whose 2nd dose is run 28 days after the primary dose.